KR102103534B1 - 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도 - Google Patents

신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도 Download PDF

Info

Publication number
KR102103534B1
KR102103534B1 KR1020197006058A KR20197006058A KR102103534B1 KR 102103534 B1 KR102103534 B1 KR 102103534B1 KR 1020197006058 A KR1020197006058 A KR 1020197006058A KR 20197006058 A KR20197006058 A KR 20197006058A KR 102103534 B1 KR102103534 B1 KR 102103534B1
Authority
KR
South Korea
Prior art keywords
water
platinum
gold
electrodes
electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197006058A
Other languages
English (en)
Korean (ko)
Other versions
KR20190027933A (ko
Inventor
아담 알. 도르프만
데이비드 에이스. 브라이스
맥스웰 에이. 그레이스
디. 카일 피어스
미카힐 메르즐라코브
마크 지. 모르텐슨
Original Assignee
클레네 나노메디슨, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 클레네 나노메디슨, 인크. filed Critical 클레네 나노메디슨, 인크.
Publication of KR20190027933A publication Critical patent/KR20190027933A/ko
Application granted granted Critical
Publication of KR102103534B1 publication Critical patent/KR102103534B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B82B3/0009—Forming specific nanostructures
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C1/00—Making non-ferrous alloys
    • C22C1/04—Making non-ferrous alloys by powder metallurgy
    • C22C1/0466—Alloys based on noble metals
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C30/00—Alloys containing less than 50% by weight of each constituent
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C5/00—Alloys based on noble metals
    • C22C5/02—Alloys based on gold
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C5/00—Alloys based on noble metals
    • C22C5/04—Alloys based on a platinum group metal
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Metallurgy (AREA)
  • Mechanical Engineering (AREA)
  • Materials Engineering (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Manufacturing & Machinery (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
  • Powder Metallurgy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
KR1020197006058A 2011-03-30 2012-03-30 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도 Active KR102103534B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161469525P 2011-03-30 2011-03-30
US61/469,525 2011-03-30
PCT/US2012/031654 WO2012135743A2 (en) 2011-03-30 2012-03-30 Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020137028744A Division KR101955735B1 (ko) 2011-03-30 2012-03-30 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도

Publications (2)

Publication Number Publication Date
KR20190027933A KR20190027933A (ko) 2019-03-15
KR102103534B1 true KR102103534B1 (ko) 2020-04-23

Family

ID=46932416

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137028744A Active KR101955735B1 (ko) 2011-03-30 2012-03-30 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도
KR1020197006058A Active KR102103534B1 (ko) 2011-03-30 2012-03-30 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020137028744A Active KR101955735B1 (ko) 2011-03-30 2012-03-30 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도

Country Status (15)

Country Link
US (3) US9387225B2 (enExample)
EP (1) EP2691082B1 (enExample)
JP (1) JP6121985B2 (enExample)
KR (2) KR101955735B1 (enExample)
CN (1) CN103764123B (enExample)
BR (1) BR112013025112A2 (enExample)
CA (1) CA2829095C (enExample)
DK (1) DK2691082T3 (enExample)
ES (1) ES2564672T3 (enExample)
IL (1) IL228356A (enExample)
MX (1) MX337439B (enExample)
PH (1) PH12013501954A1 (enExample)
RU (1) RU2617055C2 (enExample)
SG (1) SG193439A1 (enExample)
WO (1) WO2012135743A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009009143A1 (en) * 2007-07-11 2009-01-15 Gr Intellectual Reserve, Llc Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
EP2735389A1 (de) * 2012-11-23 2014-05-28 Universität Duisburg-Essen Verfahren zur Herstellung reiner, insbesondere kohlenstofffreier Nanopartikel
JP5891320B1 (ja) * 2015-02-12 2016-03-22 秋田県 ゼータ電位制御法を用いた処理方法
CN106680450B (zh) * 2017-03-23 2023-04-25 江西省农业科学院农业经济与信息研究所 水质监测装置及方法
US11674234B1 (en) * 2020-09-30 2023-06-13 National Technology & Engineering Solutions Of Sandia, Llc Electrodeposited platinum-gold alloy
CN112683710B (zh) * 2020-12-02 2024-04-16 大连理工大学 一种氯离子侵蚀下钢筋混凝土桥板加速腐蚀的试验装置
CN112935273A (zh) * 2021-01-26 2021-06-11 哈尔滨理工大学 一种室温制备CuPt合金纳米颗粒的方法
JP2022131579A (ja) 2021-02-26 2022-09-07 キオクシア株式会社 分析装置および分析方法
CN113500199B (zh) * 2021-06-10 2022-11-08 浙江大学 一种基于金铂双金属活性氧自生成纳米材料的制备方法及其产品和应用
CN113777034B (zh) * 2021-08-20 2024-04-19 嘉兴学院 金纳米双锥阵列基底及其制备方法和应用
CN114470201B (zh) * 2021-12-24 2024-03-19 上海市儿童医院 一种装载kcna5抗体的金铂纳米颗粒及其制备方法和应用
CN120504491B (zh) * 2025-07-21 2025-09-16 景德镇学院 一种稳定陶瓷釉料烧制发色的添加剂及其方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002212102A (ja) 2001-01-23 2002-07-31 Ainobekkusu Kk 電気化学的生理活性微粒子
WO2010083040A1 (en) 2009-01-15 2010-07-22 Gr Intellectual Reserve, Llc Continuous semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343047B2 (en) * 2000-02-08 2021-03-17 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US7001617B2 (en) * 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US6989157B2 (en) 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
WO2002085387A2 (en) * 2001-04-23 2002-10-31 Nucryst Pharmaceuticals Corp. A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
US20080190770A1 (en) * 2004-04-26 2008-08-14 Cap Technologies, Llc Treatment of Fluids and/or Sludge with Electro Plasma
TW200704404A (en) * 2005-03-23 2007-02-01 Shetech Co Ltd Precious metal nanocolloid solution
WO2007079452A2 (en) * 2006-01-03 2007-07-12 Gr Intellectual Reserve, Llc Methods and apparatuses for making liquids more reactive
KR100857389B1 (ko) * 2006-06-30 2008-09-11 (주)아모레퍼시픽 Ａｐ-ｇｒｒ 펩티드 또는 ａｐ-ｇｒｒ 펩티드를 포함하는펩티드사슬 및 이를 포함하는 약물전달담체
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
WO2009009143A1 (en) 2007-07-11 2009-01-15 Gr Intellectual Reserve, Llc Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom
AU2008302035A1 (en) * 2007-09-21 2009-03-26 Cytimmune Sciences, Inc. Nanotherapeutic colloidal metal compositions and methods
ES2623504T3 (es) * 2009-07-08 2017-07-11 Clene Nanomedicine, Inc. Nanocristales novedosos basados en oro para tratamientos médicos y procedimientos de fabricación electroquímica para los mismos
KR101090431B1 (ko) * 2009-08-19 2011-12-07 삼성전기주식회사 금속 씨앗을 이용한 금속 나노입자의 제조 방법 및 금속 씨앗을 함유하는 금속 나노입자

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002212102A (ja) 2001-01-23 2002-07-31 Ainobekkusu Kk 電気化学的生理活性微粒子
WO2010083040A1 (en) 2009-01-15 2010-07-22 Gr Intellectual Reserve, Llc Continuous semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom

Also Published As

Publication number Publication date
RU2013148011A (ru) 2015-05-10
SG193439A1 (en) 2013-10-30
WO2012135743A3 (en) 2014-05-01
KR20140020310A (ko) 2014-02-18
CN103764123B (zh) 2018-03-13
US20140294963A1 (en) 2014-10-02
CN103764123A (zh) 2014-04-30
ES2564672T3 (es) 2016-03-28
MX337439B (es) 2016-03-03
EP2691082B1 (en) 2016-01-13
KR101955735B1 (ko) 2019-03-07
EP2691082A2 (en) 2014-02-05
AU2012236213A1 (en) 2013-11-14
CA2829095A1 (en) 2012-10-04
US9387225B2 (en) 2016-07-12
WO2012135743A2 (en) 2012-10-04
DK2691082T3 (en) 2016-02-29
JP6121985B2 (ja) 2017-04-26
RU2617055C2 (ru) 2017-04-19
IL228356A (en) 2017-04-30
PH12013501954A1 (en) 2013-11-25
AU2012236213A2 (en) 2014-01-23
MX2013011245A (es) 2013-10-17
US20160317578A1 (en) 2016-11-03
EP2691082A4 (en) 2015-06-24
US20230172975A1 (en) 2023-06-08
NZ617018A (en) 2015-10-30
JP2014518847A (ja) 2014-08-07
CA2829095C (en) 2019-08-27
BR112013025112A2 (pt) 2020-09-29
IL228356A0 (en) 2013-12-31
KR20190027933A (ko) 2019-03-15

Similar Documents

Publication Publication Date Title
KR102103534B1 (ko) 신규한 골드-백금계 복금속 나노결정 현탁액, 그의 전기화학 제조 방법 및 그의 용도
JP7014851B2 (ja) 医学的治療のための新規の金系ナノ結晶、及び該金系ナノ結晶のための電気化学的製造方法
AU2018203373B2 (en) Novel gold-based nanocrystals
Sreeprasad et al. Noble metal nanoparticles
TW201138827A (en) Core-shell metal nanoparticles and method for manufacturing the same
AU2012236213B2 (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
NZ617018B2 (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
Chen Self-therapeutic applications of noble metal nanostructures

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20190227

Application number text: 1020137028744

Filing date: 20131030

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190307

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190502

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20200116

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20200416

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20200417

End annual number: 3

Start annual number: 1

PG1601 Publication of registration